New Treatment in Australia: A Promising Breakthrough for Weight Loss ?
Australia is currently observing the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist , representing a exciting advance in obesity treatment . Early study data have demonstrated impressive results, showing greater impact than existing treatments like semaglutide. While still un